169 related articles for article (PubMed ID: 23674508)
1. Comparison of intake and systemic relative effect potencies of dioxin-like compounds in female mice after a single oral dose.
van Ede KI; Andersson PL; Gaisch KP; van den Berg M; van Duursen MB
Environ Health Perspect; 2013 Jul; 121(7):847-53. PubMed ID: 23674508
[TBL] [Abstract][Full Text] [Related]
2. Comparison of intake and systemic relative effect potencies of dioxin-like compounds in female rats after a single oral dose.
van Ede KI; Andersson PL; Gaisch KP; van den Berg M; van Duursen MB
Arch Toxicol; 2014 Mar; 88(3):637-46. PubMed ID: 24363026
[TBL] [Abstract][Full Text] [Related]
3. Differential relative effect potencies of some dioxin-like compounds in human peripheral blood lymphocytes and murine splenic cells.
van Ede KI; Gaisch KP; van den Berg M; van Duursen MB
Toxicol Lett; 2014 Apr; 226(1):43-52. PubMed ID: 24472611
[TBL] [Abstract][Full Text] [Related]
4. Toxicology and carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Cas No. 1746-01-6), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4), and 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) in female Harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Sep; (526):1-180. PubMed ID: 17342195
[TBL] [Abstract][Full Text] [Related]
5. Relative effect potency estimates of dioxin-like activity for dioxins, furans, and dioxin-like PCBs in adults based on cytochrome P450 1A1 and 1B1 gene expression in blood.
Wimmerová S; van den Berg M; Chovancová J; Patayová H; Jusko TA; van Duursen MB; Palkovičová Murínová Ľ; Canton RF; van Ede KI; Trnovec T
Environ Int; 2016 Nov; 96():24-33. PubMed ID: 27588699
[TBL] [Abstract][Full Text] [Related]
6. Tissue distribution of dioxin-like compounds: potential impacts on systemic relative potency estimates.
van Ede KI; Aylward LL; Andersson PL; van den Berg M; van Duursen MB
Toxicol Lett; 2013 Jul; 220(3):294-302. PubMed ID: 23680695
[TBL] [Abstract][Full Text] [Related]
7. Toxicology and carcinogenesis studies of a binary mixture of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) and 2,3',4,4',5-pentachlorobiphenyl (PCB 118) (Cas No. 31508-00-6) in female Harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Nov; (531):1-218. PubMed ID: 17342196
[TBL] [Abstract][Full Text] [Related]
8. Toxicology and carcinogenesis studies of 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4) in female Harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Sep; (525):1-198. PubMed ID: 17160103
[TBL] [Abstract][Full Text] [Related]
9. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
10. Relative potency based on hepatic enzyme induction predicts immunosuppressive effects of a mixture of PCDDS/PCDFS and PCBS.
Smialowicz RJ; DeVito MJ; Williams WC; Birnbaum LS
Toxicol Appl Pharmacol; 2008 Mar; 227(3):477-84. PubMed ID: 18190939
[TBL] [Abstract][Full Text] [Related]
11. NTP technical report on the toxicology and carcinogenesis studies of 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153) (CAS No. 35065-27-1) in female Harlan Sprague-Dawley rats (Gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 May; (529):4-168. PubMed ID: 16835634
[TBL] [Abstract][Full Text] [Related]
12. Disposition of polychlorinated dibenzo-p-dioxins, dibenzofurans, and non-ortho polychlorinated biphenyls in pregnant long evans rats and the transfer to offspring.
Chen CY; Hamm JT; Hass JR; Birnbaum LS
Toxicol Appl Pharmacol; 2001 Jun; 173(2):65-88. PubMed ID: 11384209
[TBL] [Abstract][Full Text] [Related]
13. The 2005 World Health Organization reevaluation of human and Mammalian toxic equivalency factors for dioxins and dioxin-like compounds.
Van den Berg M; Birnbaum LS; Denison M; De Vito M; Farland W; Feeley M; Fiedler H; Hakansson H; Hanberg A; Haws L; Rose M; Safe S; Schrenk D; Tohyama C; Tritscher A; Tuomisto J; Tysklind M; Walker N; Peterson RE
Toxicol Sci; 2006 Oct; 93(2):223-41. PubMed ID: 16829543
[TBL] [Abstract][Full Text] [Related]
14. Relative effect potency estimates of dioxin-like activity for dioxins, furans, and dioxin-like PCBs in adults based on two thyroid outcomes.
Trnovec T; Jusko TA; Šovčíková E; Lancz K; Chovancová J; Patayová H; Palkovičová L; Drobná B; Langer P; Van den Berg M; Dedik L; Wimmerová S
Environ Health Perspect; 2013 Aug; 121(8):886-92. PubMed ID: 23665575
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of relative effect potencies (REPs) for dioxin-like compounds to derive systemic or human-specific TEFs to improve human risk assessment.
van Ede KI; van Duursen MB; van den Berg M
Arch Toxicol; 2016 Jun; 90(6):1293-305. PubMed ID: 27161441
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the CYP1A1 mRNA dose-response in human keratinocytes indicates that relative potencies of dioxins, furans, and PCBs are species and congener specific.
Sutter CH; Bodreddigari S; Sutter TR; Carlson EA; Silkworth JB
Toxicol Sci; 2010 Dec; 118(2):704-15. PubMed ID: 20819910
[TBL] [Abstract][Full Text] [Related]
17. Toxicology and carcinogenesis studies of a binary mixture of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) and 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153) (CAS No. 35065-27-1) in female Harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Aug; (530):1-258. PubMed ID: 17160104
[TBL] [Abstract][Full Text] [Related]
18. Automated dose-response analysis and comparative toxicogenomic evaluation of the hepatic effects elicited by TCDD, TCDF, and PCB126 in C57BL/6 mice.
Kopec AK; Burgoon LD; Ibrahim-Aibo D; Burg AR; Lee AW; Tashiro C; Potter D; Sharratt B; Harkema JR; Rowlands JC; Budinsky RA; Zacharewski TR
Toxicol Sci; 2010 Nov; 118(1):286-97. PubMed ID: 20702594
[TBL] [Abstract][Full Text] [Related]
19. Toxicokinetics of dioxins and other organochlorine compounds in Japanese people: association with hepatic CYP1A2 expression levels.
Watanabe MX; Kunisue T; Ueda N; Nose M; Tanabe S; Iwata H
Environ Int; 2013 Mar; 53():53-61. PubMed ID: 23333656
[TBL] [Abstract][Full Text] [Related]
20. Comparative ability of various PCBs, PCDFs, and TCDD to induce cytochrome P450 1A1 and 1A2 activity following 4 weeks of treatment.
De Vito MJ; Maier WE; Diliberto JJ; Birnbaum LS
Fundam Appl Toxicol; 1993 Jan; 20(1):125-30. PubMed ID: 8432423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
